Richard C Rosenzweig
CIK 1206725 · View on SEC EDGAR ↗
First SEC filing: Oct. 15, 2025 · Latest: Oct. 15, 2025
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 10, 2025 | XRAY | A | 81 | $11.98 | $970 | 6,143 Direct | +1.34% | Acquired | -9.4% (price as of 2026-08-21) |
| Oct. 10, 2025 | XRAY | A | 766 | — | — | 85,184 Direct | +0.91% | Acquired | (price as of 2026-08-21) |
| July 11, 2025 | XRAY | A | 59 | $16.20 | $956 | 6,062 Direct | +0.98% | Acquired | -33.0% (price as of 2026-08-21) |
| July 11, 2025 | XRAY | A | 595 | — | — | 84,417 Direct | +0.71% | Acquired | (price as of 2026-08-21) |
| April 11, 2025 | XRAY | A | 76 | $12.47 | $948 | 6,003 Direct | +1.28% | Acquired | -13.0% (price as of 2026-08-21) |
| April 11, 2025 | XRAY | A | 628 | — | — | 83,452 Direct | +0.76% | Acquired | (price as of 2026-08-21) |
| March 26, 2025 | XRAY | A | 3,927 | $18.98 | $74,534 | 5,927 Direct | +196.35% | Acquired | -42.8% (price as of 2026-08-21) |
| March 4, 2025 | XRAY | F | 1,440 | $15.59 | $22,450 | 82,823 Direct | -1.71% | Disposed | -30.4% (price as of 2026-08-21) |
| March 3, 2025 | XRAY | A | 350,100 | — | — | 350,100 Direct | — | Acquired | (price as of 2026-08-21) |
| March 3, 2025 | XRAY | F | 4,956 | $15.99 | $79,246 | 84,263 Direct | -5.55% | Disposed | -32.1% (price as of 2026-08-21) |
| March 3, 2025 | XRAY | F | 1,452 | $15.99 | $23,217 | 89,219 Direct | -1.60% | Disposed | -32.1% (price as of 2026-08-21) |
| March 3, 2025 | XRAY | A | 33,771 | — | — | 90,671 Direct | +59.35% | Acquired | (price as of 2026-08-21) |
| Jan. 10, 2025 | XRAY | A | 17 | $18.51 | $315 | 2,000 Direct | +0.86% | Acquired | -41.4% (price as of 2026-08-21) |
| Jan. 10, 2025 | XRAY | A | 383 | — | — | 56,900 Direct | +0.68% | Acquired | (price as of 2026-08-21) |
| Oct. 11, 2024 | XRAY | A | 13 | $24.50 | $318 | 1,983 Direct | +0.66% | Acquired | -55.7% (price as of 2026-08-21) |
| Oct. 11, 2024 | XRAY | A | 267 | — | — | 56,208 Direct | +0.48% | Acquired | (price as of 2026-08-21) |
| July 12, 2024 | XRAY | A | 12 | $25.80 | $310 | 1,970 Direct | +0.61% | Acquired | -57.9% (price as of 2026-08-21) |
| July 12, 2024 | XRAY | A | 288 | — | — | 55,941 Direct | +0.52% | Acquired | (price as of 2026-08-21) |
| April 12, 2024 | XRAY | A | 10 | $31.45 | $314 | 1,958 Direct | +0.51% | Acquired | -65.5% (price as of 2026-08-21) |
| April 12, 2024 | XRAY | A | 215 | — | — | 55,417 Direct | +0.39% | Acquired | (price as of 2026-08-21) |
| March 18, 2024 | XRAY | A | 1,948 | $35.59 | $69,329 | 1,948 Direct | — | Acquired | -69.5% (price as of 2026-08-21) |
| March 4, 2024 | XRAY | A | 38,900 | — | — | 38,900 Direct | — | Acquired | (price as of 2026-08-21) |
| March 4, 2024 | XRAY | A | 11,644 | — | — | 55,202 Direct | +26.73% | Acquired | (price as of 2026-08-21) |
| March 1, 2024 | XRAY | F | 4,736 | $33.27 | $157,567 | 43,558 Direct | -9.81% | Disposed | -67.4% (price as of 2026-08-21) |
| March 1, 2024 | XRAY | F | 1,356 | $33.27 | $45,114 | 48,294 Direct | -2.73% | Disposed | -67.4% (price as of 2026-08-21) |
| Jan. 12, 2024 | XRAY | A | 194 | — | — | 49,650 Direct | +0.39% | Acquired | (price as of 2026-08-21) |
| Oct. 13, 2023 | XRAY | A | 201 | — | — | 49,291 Direct | +0.41% | Acquired | (price as of 2026-08-21) |
| July 14, 2023 | XRAY | A | 171 | — | — | 49,090 Direct | +0.35% | Acquired | (price as of 2026-08-21) |
| April 14, 2023 | XRAY | A | 174 | — | — | 48,919 Direct | +0.36% | Acquired | (price as of 2026-08-21) |
| March 3, 2023 | XRAY | A | 30,800 | — | — | 30,800 Direct | — | Acquired | (price as of 2026-08-21) |
| March 3, 2023 | XRAY | A | 38,720 | — | — | 48,745 Direct | +386.23% | Acquired | (price as of 2026-08-21) |
| March 3, 2023 | XRAY | A | 10,003 | — | — | 10,025 Direct | +45468.18% | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 10, 2025 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (81) | — | — | 81 | Acquired |
| July 11, 2025 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (59) | — | — | 59 | Acquired |
| April 11, 2025 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (76) | — | — | 76 | Acquired |
| March 26, 2025 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (3,927) | — | — | 3,927 | Acquired |
| March 3, 2025 | XRAY | Stock Option (Right to Buy) | Common Stock (350,100) | $15.99 | March 3, 2035 | 350,100 | Acquired |
| Jan. 10, 2025 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (17) | — | — | 17 | Acquired |
| Oct. 11, 2024 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (13) | — | — | 13 | Acquired |
| July 12, 2024 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (12) | — | — | 12 | Acquired |
| April 12, 2024 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (10) | — | — | 10 | Acquired |
| March 18, 2024 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (1,948) | — | — | 1,948 | Acquired |
| March 4, 2024 | XRAY | Stock Option (Right to Buy) | Common Stock (38,900) | $33.28 | March 4, 2034 | 38,900 | Acquired |
| March 3, 2023 | XRAY | Stock Option (Right to Buy) | Common Stock (30,800) | $38.74 | March 3, 2023 | 30,800 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 2, 2023 | XRAY | Common Stock | 22 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
XRAY
General Counsel| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $452,727 | — | $1,366,619 | $1,311,618 | $300,128 | — | $1,262,588 | $4,693,681 |
| 2024 | $575,426 | — | $1,196,500 | $387,214 | $260,601 | — | $86,610 | $2,506,351 |
| 2023 | $464,110 | $250,000 | $2,747,904 | $386,978 | $420,131 | — | $84,879 | $4,354,002 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.